Stanley M. Gartler, Trailblazing Cancer Geneticist, Passes Away at Age 102

Stanley M. Gartler, a molecular biologist and geneticist who supplied the earliest strong evidence that tumors arise from a single mutated cell and who exposed serious flaws in the first immortal human cell line, passed away on May 25 at his Seattle residence. He was 102.

His passing, which received little attention initially, was confirmed by his nephew, Dr. Richard Weiner.

Starting in the early 1960s, Dr. Gartler investigated the genetic roots of cancer at the University of Washington, where he joined the genetics faculty in 1957 and kept his laboratory active until 2007.

At the dawn of the 20th century, German zoologist Theodor Boveri hypothesized that tumors originate from a single cell that proliferates unchecked, though he could not provide proof.

Collaborating with pathologist David Linder, Dr. Gartler examined benign uterine tumors, commonly called fibroids, excised during hysterectomies in Black women.

Women possess two X chromosomes per cell, men have one X and one Y. Through a random mechanism known as X inactivation, most genes on one of the X chromosomes in females are silenced early in embryonic development. Dr. Gartler recognized that the silencing of the X‑linked G6PD gene could reveal the lineage of individual cells.

In a 1965 Science paper, Dr. Gartler and Dr. Linder demonstrated that normal uterine tissue contained a mixture of two G6PD variants, A and B, in about equal proportions, whereas tumor tissue displayed only one variant—either A or B—indicating that the tumor arose from a single cell.

“‘We really had to understand cancer’s biology to have any chance of treating it,’ said Dr. Gail Jarvik, head of the University of Washington’s medical genetics division, in an interview. ‘All chemotherapy and today’s targeted therapies rest on a clear grasp of this mutational biology.'”

Also in 1965, while examining variable genetic markers in human cells, Dr. Gartler assembled a set of permanent human cell lines—easily cloned cultures invaluable for disease research and drug and vaccine development.

He discovered something highly improbable: in 18 cultures presumed to be independent, the genetic markers were identical, each harboring the rare A variant of the G6PD gene, which occurs almost exclusively in individuals of African descent.

He realized that these allegedly distinct cultures had been contaminated and overtaken by the first permanent human cell line, created in 1951 at Johns Hopkins Hospital in Baltimore and known as the HeLa (pronounced hee‑lah) line.

HeLa derives from the name Henrietta Lacks, a Black woman who succumbed to cervical cancer in 1951. Her genetic material, taken from a biopsy shortly before her death, was distributed and studied worldwide without her consent or her family’s awareness.

The HeLa line proved instrumental in breakthroughs ranging from the polio vaccine to cancer research, cell biology, in vitro fertilization, cloning, and chemotherapy. Yet Dr. Gartler noted a troubling issue: HeLa cells could readily contaminate other cultures, hitchhiking on dust particles, lab coats, or unwashed hands.

Researchers believing they were investigating kidney, liver, or breast cancer cells were, he suggested, actually examining HeLa‑derived cervical cancer cells that had overgrown the original specimens. He later attributed the contamination to lax laboratory techniques.

At a 1966 Pennsylvania conference on cell tissue and organ culture, Dr. Gartler presented his findings to a stunned and skeptical audience of 700 scientists, warning that work on presumed original cell lines was now ‘open to serious question’ and should arguably be discarded.

Rebecca Skloot recounted the conference in her 2010 bestseller, *The Immortal Life of Henrietta Lacks*. Michael Gold, author of the 1985 book *A Conspiracy of Cells: One Woman’s Immortal Legacy and the Medical Scandal It Caused*, said in an interview that Dr. Gartler’s findings had an enormous scientific impact.

“‘He really raised the red flag,’ Mr. Gold said, describing a widespread problem that ‘wasted countless hours and untold millions of dollars’ on flawed science.”

Many researchers, Mr. Gold added, ‘didn’t particularly want to hear that news,’ yet ‘a critical mass’ reluctantly accepted Dr. Gartler’s conclusions.

Dr. Gartler’s discovery is credited with spurring better laboratory quality control and stricter cell‑line authentication. The HeLa story became a defining lesson of 20th‑century medicine, highlighting ethical concerns over patient informed consent, privacy, and families’ rights to compensation for research using a relative’s cells.

In a 2012 lecture, Dr. Gartler emphasized the necessity of anonymity and privacy in research—a dignity that had been denied to Henrietta Lacks.

“‘I personally wouldn’t want to be remembered for a cancer cell,’ he remarked.”

Stanley Michael Gartler was born on June 9, 1923, in Los Angeles to parents who had emigrated from Romania. His father, George Gartler, operated a dry‑cleaning plant, and his mother, Delvira (Kupferberg) Gartler, managed the household.

He enrolled at UCLA in 1941, initially interested in agriculture, but left the following year to join the military. During World War II he served in the Army Air Forces as a radio operator and machine‑gunner on a B‑26 bomber flying missions over Europe.

After returning to UCLA to finish his bachelor’s degree, he earned a Ph.D. in genetics from UC Berkeley in 1952, focusing on plant breeding and cultivating an interest in human genetics during a postdoctoral fellowship at Columbia University. He subsequently became the inaugural faculty member of the newly established Division of Medical Genetics at the University of Washington.

His wife, Marion Mitchelson Gartler—a writer and editor who also invented a pickpocket‑thwarting vest—passed away in 2016. He left no immediate survivors.

In 1962, Dr. Gartler and two co‑authors published an influential paper describing a girl with heterochromatic eyes and atypical genitalia. As Dr. Jarvik of the University of Washington noted, it was the first demonstration of mixed XX and XY cells in a human, probably resulting from an early fusion of twin fetuses.

“‘It really shows that sex determination is far more complex than a simple XX/XY chromosome count,’ Dr. Jarvik said, ‘and that the human body can accommodate considerable variability.'”

Source link